Abstract
Pantothenate kinase-associated neurodegeneration is an autosomal recessive disorder with progressive impairment of movement, vision, and cognition. The disease is the most common form of a clinically and genetically heterogeneous group of disorders named neurodegeneration with brain iron accumulation that share the distinctive feature of brain iron overload in the basal ganglia. Pantothenate kinase-associated neurodegeneration is caused by mutations in the pantothenate kinase 2 (PANK2), coding for the enzyme that phosphorylates vitamin B5 (pantothenate, pantothenic acid) in the first reaction of the coenzyme A biosynthetic pathway. In humans and mice, four genes express different isoforms of pantothenate kinase enzymes, which are targeted to different subcellular compartments. In Drosophila, a single pantothenate kinase gene encodes seven different isoforms responsible for all pantothenate kinase activity within the cell. Here, we describe what is known of the murine and Drosophila models, and we discuss their limits and possible exploitation as model systems to test experimental therapeutic approaches.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
